Literature DB >> 21629134

Ocular manifestations of xeroderma pigmentosum at a tertiary eye care center in Saudi Arabia.

Abdullah M Alfawaz1, Hailah M Al-Hussain.   

Abstract

PURPOSE: To study the clinical profile of Saudi cases of xeroderma pigmentosum (XP).
DESIGN: This is a single-center, retrospective, consecutive case series of all cases of XP seen at King Khaled Eye Specialist Hospital from January 1, 1986, to December 31, 2006. The main outcome measures were clinical features, visual outcome, and histopathologic findings.
RESULTS: Of 33 patients initially included in this study, 6 were excluded from the final analysis because of either unconfirmed diagnosis of XP or insufficient follow up. The final analysis included 27 patients (14 female patients, 13 male patients). A history of consanguinity was present in the parents of one third of our patients. The age at onset of ocular complications ranged from 5 to 67 years (median age, 19 years). The number of patients with no light perception (NLP) increased from 1 patient (3.7%) at the initial visit to 5 patients (18.5%) at the last visit. In 13 of 27 patients (48.1%), conjunctival tumors were observed; 10 tumors were confirmed histopathologically to be squamous cell carcinomas. Basal cell carcinoma (BCC) was the most common histopathologic diagnosis of eyelid tumors and was noted in 4 patients (14.8%). Furthermore, 10 patients (37.0%) had a history of skin malignancy, and 5 patients (18.1%) had neurologic abnormalities.
CONCLUSION: Patients with XP who presented to a tertiary eye care center in Saudi Arabia had a high percentage of consanguinity in parents and late onset of ocular complications. Additionally, XP behaved aggressively in both malignancy profile and visual outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21629134     DOI: 10.1097/IOP.0b013e31821c7323

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  4 in total

1.  Clinicopathological Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum.

Authors:  Maria J Suarez; Roxana Rivera-Michlig; Sander Dubovy; Fausto J Rodriguez
Journal:  Ocul Oncol Pathol       Date:  2015-11-12

2.  Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.

Authors:  Brian P Brooks; Amy H Thompson; Rachel J Bishop; Janine A Clayton; Chi-Chao Chan; Ekaterini T Tsilou; Wadih M Zein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Nicholas T Iliff; Porcia Bradford; John J Digiovanna; Kenneth H Kraemer
Journal:  Ophthalmology       Date:  2013-04-16       Impact factor: 12.079

3.  Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.

Authors:  Lenah Alwatban; Yousef Binamer
Journal:  Ann Saudi Med       Date:  2017 May-Jun       Impact factor: 1.526

4.  Xeroderma Pigmentosum: Ocular Findings in an Isolated Brazilian Group with an Identified Genetic Cluster.

Authors:  Maria Claudia Schelini; Luis Fernando O B Chaves; Marcia C Toledo; Francisco W Rodrigues; Tauan de Oliveira; David L C Isaac; Marcos Avila
Journal:  J Ophthalmol       Date:  2019-10-31       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.